Rituximab Maintenance Therapy After Autologous Stem-Cell Transplantation in Patients With Relapsed CD20(+) Diffuse Large B-Cell Lymphoma: Final Analysis of the Collaborative Trial in Relapsed Aggressive Lymphoma

PURPOSE: The standard treatment for relapsed diffuse large B-cell lymphoma (DLBCL) is salvage chemotherapy followed by high-dose therapy and autologous stem-cell transplantation (ASCT). The impact of maintenance rituximab after ASCT is not known. PATIENTS AND METHODS: In total, 477 patients with CD2...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Main Authors: Gisselbrecht, Christian, Schmitz, Norbert, Mounier, Nicolas, Singh Gill, Devinder, Linch, David C., Trneny, Marek, Bosly, Andre, Milpied, Noel J., Radford, John, Ketterer, Nicolas, Shpilberg, Ofer, Dührsen, Ulrich, Hagberg, Hans, Ma, David D., Viardot, Andreas, Lowenthal, Ray, Brière, Josette, Salles, Gilles, Moskowitz, Craig H., Glass, Bertram
Format: Artigo
Sprog:Inglês
Udgivet: American Society of Clinical Oncology 2012
Fag:
Original Reports
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC3646314/
https://ncbi.nlm.nih.gov/pubmed/23091101
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JCO.2012.41.9416
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker